Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: a Markov decision analysis von de Geus, S.W.L, Evans, D.B, Bliss, L.A, Eskander, M.F, Smith, J.K, Wolff, R.A, Miksad, R.A, Weinstein, M.C, Tseng, J.F

Volltext

Regional disparities in pancreatic adenocarcinoma treatment: Is multimodality therapy the answer? von Kasumova, G.G, Eskander, M.F, de Geus, S.L, Matiotti, M, Ng, S.C, Tseng, J.F

Volltext

Pancreatic cancer variants: Same name – different prognosis von Eskander, M.F, Kasumova, G.G, dGeus, S.W.L, Ng, S.C, Kent, T.S, Tseng, J.F

Volltext

How did COVID-19 influence use of neoadjuvant therapy before surgery for patients with HPB cancers? von Manzella, A., Eskander, M.F., Grandhi, M.S., In, H., Langan, R.C., Kennedy, T., August, D., Alexander, H.R., Beninato, T., Pitt, H.A.

Volltext

Did COVID-19 disrupt surgery for patients with pancreatic and hepatic malignancies? von Manzella, A., Eskander, M.F., Grandhi, M.S., In, H., Langan, R.C., Kennedy, T., August, D., Alexander, H.R., Beninato, T., Pitt, H.A.

Volltext

In search of lost time: delays in adjuvant therapy for pancreatic adenocarcinoma von Hamad, A., Eskander, M.F., Shen, C., Bhattacharyya, O., Fisher, J.L., Oppong, B.A., Obeng-Gyasi, S., Tsung, A.

Volltext

Upper Extremity Deep Venous Thrombosis After Port Insertion: What Are the Risk Factors? von Tabatabaie, O., Kasumova, G.G., Kent, T.S., Eskander, M.F., Fadayomi, A.B., Ng, S.C.

Volltext

Acrylamide detection and reduction in meat products using organic acids, fruit extracts, and probiotics von Hamad, Gamal M., Abushaala, Mukhtar M.F., Abushaala, Sohayla M., Ehmeza, Nasser T., Hassan Ahmed, Essa Mohamed, Elshaer, Samy E., Abdelhiee, Ehab Y., Eskander, Michael, Elaziz, Adel Abd, Mehany, Taha

Volltext